DOCETAXEL ANHYDROUS

DOCETAXEL ANHYDROUS · Hospira, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DOCETAXEL ANHYDROUS, covering 2018-08-24 to 2023-09-15. Get the full timeline:

Most recent: FDA Approved: DOCETAXEL ANHYDROUS — Supplemental Application (Meitheal Pharmaceuticals Inc)